[Brainlife] Desferoxamine (DFO)

Desferoxamine

Home > Database > Treatment > Desferoxamine (DFO)

Contents

Brain Tumors

	Pouya N. Dayani, Maria C. Bishop, Keith Black, Paul M. Zeltzer Desferoxamine (DFO) – Mediated Iron Chelation: Rationale for a Novel Approach to Therapy for Brain Cancer Journal of Neuro-Oncology, 67 (3): 367-377, May 2004. (Abstract+)

	HOME • CURRENT NEURO-ONCOLOGY • GLIOBLASTOMA REPORTS • BRAIN TUMOR MEDICAL DATABASE • SERVICES • TREATMENT OPTIONS FOR GLIOBLASTOMA DATABASE by Section: Classification \| Diagnosis \| Epidemiology \| Etiology & Pathogenesis \| Integrative Medicine \| Overall Management \| Prognosis \| Psychosocial Aspects \| Stem Cells \| Treatment DATABASE by Tumor: Glioblastoma \| Medulloblastoma \| Other Tumors • SERVICES: About BrainLife \| Children's Corner \| Dedication \| E-mail Alerts \| Journals \| Privacy Policy \| Publications \| Search \| SiteMap
	This site complies with the HONcode standard for trustworthy health information: verify here	bottom